— Know what they know.
Not Investment Advice

RVMDW NASDAQ

Revolution Medicines, Inc. Warrant
1W: +2.4% 1M: -22.6% 3M: +1.8% YTD: +867.9% 1Y: +2279.1%
$9.38
+0.53 (+5.99%)
After Hours: $8.46 (-0.92, -9.81%)
Weekly Expected Move ±16.1%
$6 $8 $9 $11 $12
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 24 · $39.1B mcap · 193M float · 0.022% daily turnover · Short 53% of daily vol
Credit Risk of going bust: lower than 73% of companies Debt: 1.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.8%), Revolution Medicines, Inc. Warrant would be worth roughly what it owes.
Total debt $641.9M against a stock market value of $39.42B.
Distance to default 8.06 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $243.7M (short-term plus half of long-term), stock volatility 61.7%; Altman Z'' 1.52. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
☀️
Sunny
+1099950.4% YTD avg
2026 Now
☀️
Sunny
Below typical
20yr Avg YTD
+1099950.4%
Day 26 of 252
2026 YTD
+67.8%
Below 20yr avg
Typical Vol
251%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+1216616.4%
33% win 386% vol
Feb
20yr
💨
+7.3%
67% win 283% vol
Mar
20yr
⛈️
-30.0%
0% win 324% vol
Apr
20yr
💨
+146.2%
100% win 456% vol
May
20yr
⛈️
-8.5%
67% win 462% vol
Jun
20yr
💨
+53.5%
67% win 271% vol
Jul
20yr
💨
+10.0%
67% win 232% vol
Aug
20yr
⛈️
-10.3%
33% win 219% vol
Sep
20yr
💨
+37.2%
67% win 260% vol
Oct
20yr
💨
+13.9%
67% win 251% vol
Now: -18.0%
Nov
20yr
💨
+1833381.9%
100% win 24492193% vol
Dec
20yr
⛈️
-28.6%
33% win 222% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: +67.8%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms